436
Views
8
CrossRef citations to date
0
Altmetric
Letters

Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

, , , , , , , , , , , , , , , , , , , , & show all
Pages 418-421 | Accepted 01 Sep 2017, Published online: 09 Jan 2018
 

Acknowledgements

The Danish Rheumatologic Biobank is acknowledged for biological material and for data regarding handling and storage. The Danish Regions and the Danish Rheumatism Association are acknowledged for funding of the Danish Rheumatologic Biobank. We thank the Departments of Biochemistry and Rheumatology for collection of blood samples within the Danish Rheumatologic Biobank and for reporting of corresponding clinical data in the DANBIO registry. We thank Rolf A. Klaassen at the Department of Medical Biochemistry, Oslo University Hospital, Radiumhospitalet, Oslo, Norway, for technical assistance, and Zitelab for data management.

This study was supported by an unrestricted grant from AbbVie.

Additional information

Funding

This work was supported by the AbbVie [Unrestricted grant];

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.